Analisis Kadar Prothrombin Time (PT) Pada Pasien Diabetes Mellitus Tipe 2

Nurhilaliyah Nurhilaliyah, Dewi Susandra, A. Meryam Susanti

Abstract


Prothrombin Time (PT) levels are an important parameter in laboratory tests used to measure blood clotting time through the extrinsic pathway and the common pathway. In patients with Type 2 Diabetes Mellitus, metabolic disorders can affect the coagulation system and increase the risk of bleeding or thrombosis. This study aims to determine the relationship between blood sugar levels and Prothrombin Time levels in patients with Type 2 Diabetes Mellitus. This study employed an analytical observational design with a cross-sectional approach. The sample consisted of 30 Type 2 Diabetes Mellitus patients undergoing outpatient or inpatient care at Labuang Baji General Hospital in Makassar. Data collection was conducted through blood sampling by medical staff, followed by blood glucose and Prothrombin Time measurements in the laboratory. Data analysis utilized Pearson's correlation test. The results showed that most patients had PT levels within the normal range despite high blood sugar levels. However, some patients experienced a significant increase in PT levels, which may indicate coagulation disorders. Statistical tests revealed a weak and statistically insignificant association between blood sugar levels and PT. The conclusion of this study is that blood sugar levels are not significantly associated with Prothrombin Time levels in patients with Type 2 Diabetes Mellitus

Keywords


blood coagulation; blood sugar; prothrombin time; type 2 diabetes mellitus

Full Text:

PDF

References


Archie, A. M., Sangging, P. R. A., Ismunandar, H., & Tjiptaningrum, A. (2022). Gangguan Hemostasis dan Covid-19. Medical Profession Journal of Lampung, 12(1): 14–25. https://doi.org/10.53089/medula.v12i1.369.

Ardina, R., Sartika, F., & Nainggolan, L. P. (2020). APTT (Activated Partial Thromboplastin Time) dan (Prothrombin Time) pada Penderita Diabetes Melitus Tipe 2 di RSUD dr. Doris Sylvanus Palangkaraya. Borneo Journal of Medical Laboratory Technology, 2(2): 125–129. https://doi.org/10.33084/bjmlt.v2i2.1384.

Astarini, M. I. A., Maryuti, I. A., Pae, K., & Mare, A. C. B. (2024). Penyuluhan Kesehatan Dan Pemeriksaan Kadar Gula Darah Sebagai Upaya Pencegahan Diabetes Melitus Di Desa Curah Cottok, Situbondo. Peka: Jurnal Pengabdian Kepada Masyarakat, 7(1): 70–79. https://doi.org/10.33508/peka.v7i1.5605.

Basuki, R., & Husen, F. (2022). Karakteristik Dan Gambaran Diagnosa Komplikasi Pasien Diabetes Di Rumah Sakit Umum Aghisna Sidareja. Jurnal Bina Cipta Husada, 18(2): 1–15.

Bingga, I. A. (2021). Kaitan Kualitas Tidur Dengan Diabetes Melitus Tipe 2. Medika Hutama, 2(4): 1047–1052. https://jurnalmedikahutama.com/index.php/JMH/article/view/214.

Caturano, A., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Iadicicco, I., Donnarumma, M., Galiero, R., Acierno, C., Sardu, C., Russo, V., Vetrano, E., Conte, C., Marfella, R., Rinaldi, L., & Sasso, F. C. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants, 14(72): 1–28. https://doi.org/10.3390/antiox14010072.

Darenskaya, M. A., Kolesnikova, L. I., & Kolesnikov, S. I. (2021). Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bulletin of Experimental Biology and Medicine, 171(2): 179–189. https://doi.org/10.1007/s10517-021-05191-7.

Denggos, Y. (2023). Penyakit Diabetes Mellitus Umur 40-60 Tahun di Desa Bara Batu Kecamatan Pangkep. Healthcaring: Jurnal Ilmiah Kesehatan, 2(1): 55–61. https://doi.org/10.47709/healthcaring.v2i1.2177.

Lestari, L., Zulkarnain, Z., & Sijid, A. (2021). Diabetes Melitus: Review Etiologi, Patofisiologi, Gejala, Penyebab, Cara Pemeriksaan, Cara Pengobatan dan Cara Pencegahan. UIN Alauddin Makassar, 1(2): 237–241.

Li, X., Weber, N. C., Cohn, D. M., Hollmann, M. W., Devries, J. H., Hermanides, J., & Preckel, B. (2021). Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. Journal of Clinical Medicine, 10(11): https://doi.org/10.3390/jcm10112419.

Nikma, N. (2022). Hubungan Lama Menderita Diabetes Dengan Kadar Prothrombin Time (PT) Dan Activated Partial Thromboplatin Time (APTT). Jurnal Kesehatan, 15(1): 62–66. https://doi.org/10.32763/juke.v15i1.473.

Novia, N., Wahyuni, I., & Wironegoro, R. (2023). Hubungan Derajat Katarak Dan Durasi Diabetes Melitus Tipe 2 Di Instalasi Rawat Jalan Mata Rsud Dr. Soetomo Surabaya. Jurnal Ners, 7(1): 251–259. https://doi.org/10.31004/jn.v7i1.13122.

Safitri, F., Prihandono, D. S., & Rica, F. N. (2024). Gambaran Kadar Prothobin Time (Pt) Dan Activated Partial Thromboplastin Time (Aptt) Pada Pasien Diabetes Mellitus Di Rumah Sakit Abdul Wahab Sjahranie Samarinda, 4(2): 113–119.

Wang, X., & Cheng, Z. (2020). Cross-Sectional Studies: Strengths, Weaknesses, and Recommendations. Chest, 158(1): S65–S71. https://doi.org/10.1016/j.chest.2020.03.012.

Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology, 14: 1–24. https://doi.org/10.3389/fendo.2023.1149239.




DOI: https://doi.org/10.52364/sehati.v5i2.103

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Nurhilaliyah Nurhilaliyah, Dewi Susandra, A. Meryam Susanti

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.